(Press-News.org) A commonly prescribed antibiotic could help reduce the risk of some young people developing schizophrenia, new research suggests.
Experts found that patients of adolescent mental health services who were treated with the antibiotic doxycycline were significantly less likely to go on to develop schizophrenia in adulthood compared with patients treated with other antibiotics.
Experts say the findings highlight the potential to repurpose an existing, widely used medication as a preventive intervention for severe mental illness.
Schizophrenia is a severe mental disorder that typically emerges in early adulthood and is often associated with hallucinations and delusional beliefs.
To better understand potential ways of preventing the condition, researchers from the University of Edinburgh, in collaboration with the University of Oulu and University College Dublin, applied advanced statistical modelling to large-scale healthcare register data from Finland.
The team analysed data from more than 56,000 adolescents attending mental health services who had been prescribed antibiotics. They found that those treated with doxycycline had a 30–35 per cent lower risk of developing schizophrenia than peers who received other antibiotics.
The researchers hypothesised that the protective effect could be linked to doxycycline’s impact on inflammation and brain development.
Doxycycline is a broad-spectrum antibiotic commonly used to treat infections and acne. Previous studies suggest it can reduce inflammation in brain cells and influence synaptic pruning – a natural process where the brain refines its neural connections. Excessive pruning has been associated with the development of schizophrenia.
Further analyses showed that the lower risk wasn’t simply because the young people may have been treated for acne rather than having infections, and was unlikely to be explained by other hidden differences between the groups.
Professor Ian Kelleher, study lead and Professor of Child and Adolescent Psychiatry at the University of Edinburgh, said: “As many as half of the people who develop schizophrenia had previously attended child and adolescent mental health services for other mental health problems. At present, though, we don’t have any interventions that are known to reduce the risk of going on to develop schizophrenia in these young people. That makes these findings exciting.
“Because the study was observational in nature and not a randomised controlled trial, it means we can’t draw firm conclusions on causality, but this is an important signal to further investigate the protective effect of doxycycline and other anti-inflammatory treatments in adolescent psychiatry patients as a way to potentially reduce the risk of developing severe mental illness in adulthood.”
The study is published in the American Journal of Psychiatry: https://psychiatryonline.org/doi/10.1176/appi.ajp.20240958 [URL will become active after embargo lifts]. It involved researchers from the University of Edinburgh, the University of Oulu, University College Dublin, and St John of God Hospitaller Services Group, and was funded by the Health Research Board.
For further information, please contact: Guy Atkinson, Press and PR Office, 07816 392904, guy.atkinson@ed.ac.uk
END
Common antibiotic may reduce schizophrenia risk, study shows
2025-11-05
ELSE PRESS RELEASES FROM THIS DATE:
Delta.g appoints current Chair of Serendipity Capital and former HSBC Holdings Group CFO Ewen Stevenson as Chair of the Board
2025-11-05
Delta.g, the UK quantum technology company pioneering quantum gravity sensing for subsurface intelligence, today announced the appointment of Ewen Stevenson as Chair of its Board of Directors, effective immediately.
Ewen Stevenson is a veteran banker with over 20 years of senior management experience and a record in strategic transformation, value creation, innovation, and leadership. He is currently Chair of Serendipity Capital who led Delta.g’s recently closed seed funding round. Prior to Serendipity Capital, he served as Group Chief Financial Officer of HSBC Holdings, following four years as Group Chief Financial Officer of The Royal Bank of Scotland. Prior ...
How much benefit comes from programs aimed at reducing pollution?
2025-11-05
Because policies to address pollution are costly to implement and impose social burdens, it is important to understand the full benefits of pollution-reducing programs. An article in Health Economics provides compelling evidence that one such program offered considerable benefits for infant health, especially in vulnerable populations.
Based on an analysis of more than a decade of US birth records, the research shows that the Nitrogen Oxide Budget Trading Program—a cap-and-trade initiative to reduce ozone pollution—significantly improved infant health outcomes, particularly among Black, low-income, and single mothers.
The program ...
What factors determine the severity and outcomes of cyberwarfare between countries?
2025-11-05
Cyberwarfare between nation states has become increasingly common in recent years. To address several important questions that this phenomenon raises, scientists developed a game theoretical model of cyberwarfare between nations.
Their research, which is published in Economic Inquiry, focuses on factors that determine the severity and outcomes of cyber conflicts. With a two-country model—where nations invest in offensive or defensive cyber capabilities across networked systems—the investigators considered different scenarios where the Attacker is the ...
Can therapies against cellular aging help treat metabolic diseases?
2025-11-05
A growing body of evidence implicates cellular senescence—when cells age and permanently stop dividing—as an important contributor to metabolic dysfunction that can lead to obesity, type 2 diabetes, and metabolic syndrome. A review in the Journal of Internal Medicine explores the research connecting senescent cells to metabolic diseases and highlights the potential of “senotherapeutics” in treatment strategies.
The authors note that senescent cells accumulate in metabolic tissues where they secrete factors that disrupt tissue ...
New insights on gut microbes that prevent formation of cancer-causing compounds
2025-11-05
Nitrogen metabolism of gut bacteria can provide health benefits. Specifically, gut microbes metabolize dietary nitrates and nitrites and prevent the formation of cancer-causing compounds called nitrosamines. New research published in The FEBS Journal sheds light on these processes and pinpoints which types of bacteria are most important.
Investigators found that Escherichia coli—and to a lesser extent, species of the genera Lactobacillus, Bacteroides and Phocaeicola—can efficiently metabolize different forms of nitrogen, thus ...
Preventing dangerous short circuits in lithium batteries
2025-11-05
Lithium-metal batteries are among the most promising technologies for energy storage. They offer significantly more energy in less space — and at a lower weight. However, one phenomenon slows down their development: tiny, needle-like metal structures called dendrites, made of lithium. They can grow uncontrollably inside the battery and cause devastating short circuits. Until now, solid electrolytes, including polymer-based electrolytes, have been considered a way to suppress this growth.
“Electrolytes are responsible for transporting lithium ions back and forth between the two electrodes inside a battery — making ...
Successful bone regeneration using stem cells derived from fatty tissue
2025-11-05
An Osaka Metropolitan University team has used stem cells extracted from adipose, the body’s fatty tissue, to treat spine fractures in rats similar to those caused by osteoporosis in humans. These cells offer the advantages of being easy to collect, even from elderly individuals, and causing little stress to the body, suggesting a non-invasive way of treating bone diseases.
Osteoporosis is a disease that causes bones to become brittle and prone to fractures. Due to the aging of the population, the number of patients in Japan is estimated to ...
ELSI to host first PCST Symposium in Japan, advancing science communication across Asia
2025-11-05
The Earth-Life Science Institute (ELSI) at Institute of Science Tokyo is proud to announce that it will host the PCST Japan Symposium 2025, to be held from 11–13 November 2025. This joint international symposium marks the first time the Public Communication of Science and Technology (PCST) Network brings a symposium to Japan, and the seventh conference of the Japan SciCom Forum (JSF).
The symposium will bring together researchers, practitioners, educators, and policymakers from across Asia and beyond to explore the strategic development of science communication in non-Western contexts. It is organised around two central questions that guide its themes: ‘how can we establish ...
Researchers improve marine aerosol remote sensing accuracy using multiangular polarimetry
2025-11-05
Recently, a research group led by Prof. SUN Xiaobing from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, investigated the impact of multiangular polarimetry on the quantification of marine aerosol remote sensing applications.
Their findings were published in the Optics Express.
Aerosols are one of the most uncertain components in the quantification of climate radiative forcing, while polarimetry helps to improve the characterization of the microphysical properties of atmospheric aerosol.
In this study, the team investigated the importance of the spectral range, the spectral band, the number of viewing angles, and ...
Alzheimer’s Disease can hijack communication between brain and fat tissue, potentially worsening cardiovascular and metabolic health
2025-11-05
A recent study from Houston Methodist sheds light on how Alzheimer’s disease may contribute to larger health issues by hijacking the body’s ability to regulate its metabolism. Researchers have discovered that along with the negative effects an Alzheimer’s diagnosis brings, the disease can also sabotage messages between nerves and blood vessels in fat tissue, which can worsen heart and metabolic conditions such as stroke, heart disease and diabetes.
The first-of-its-kind research, “Alzheimer’s disease disrupts intra-adipose neurovascular contact,” ...